Methyl 2-(trans-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)acetate, 97.0%, 1g

Ethyl 3,5-dimethyl-1H-pyrazole-4-carboxylate, 95.0%, 10g

5-Bromo-2-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

(E)-3-(3-(Trifluoromethyl)phenyl)acrylaldehyde, 95.0%, 100g

4-AMINO-1-METHYL-1H-PYRAZOLE-3-CARBONITRILE, 95.0%, 25g

3-butyl-1-methylpiperazin-2-one, 95.0%, 5g

N-(2-(2-(2-(3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 90%, 1g

Methyl 4-formyl-3-methoxybenzoate, 95.0%, 5g

2-(Bis(3,5-di-tert-butylphenyl)phosphino)-N-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)benzamide, 100mg

3-Chloromethyl-5-thiophen-2-yl-isoxazole, 95.0%, 10g

3,5-Diaminobenzoic Acid>98.0%(HPLC)(T)100g

5-Bromo-2-(bromomethyl)benzonitrile, 95.0%, 250mg

2-(2,5-bis(Trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg